Current knowledge on pancreatic cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Therapeutics

Background:

• Pancreatic cancer is a leading cause of cancer death with low survival rates.
• Its development involves oncogene activation, tumor suppressor gene inactivation, and signaling pathway deregulation.
• Targeting these molecular alterations is a key strategy for pancreatic cancer treatment.

Purpose of the Study:

• To critically review current knowledge on pancreatic cancer.
• To discuss molecular, biochemical, clinical, and therapeutic aspects.
• To identify reasons for the failure of targeted therapies in clinical trials.

Main Methods:

• Literature review of molecular, biochemical, clinical, and therapeutic aspects of pancreatic cancer.
• Critical analysis of current knowledge and targeted therapy approaches.
• Evaluation of factors contributing to the lack of clinical translation.

Main Results:

• Pancreatic cancer progression is driven by specific genetic and signaling pathway alterations.
• Targeted therapies have shown efficacy in preclinical settings but limited success in patients.
• Clinical trial failures are attributed to incomplete biological understanding and suboptimal agent selection.

Conclusions:

• A deeper understanding of pancreatic cancer biology is crucial for developing effective treatments.
• Improved strategies are needed to translate preclinical findings into successful clinical outcomes.
• Further research into molecular targets and therapeutic agents is essential for improving patient survival.